Cargando…
An urgent call to raise the bar in oncology
Important breakthroughs in medical treatments have improved outcomes for patients suffering from several types of cancer. However, many oncological treatments approved by regulatory agencies are of low value and do not contribute significantly to cancer mortality reduction, but lead to unrealistic p...
Autores principales: | Schnog, John-John B., Samson, Michael J., Gans, Rijk O. B., Duits, Ashley J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365561/ https://www.ncbi.nlm.nih.gov/pubmed/34400802 http://dx.doi.org/10.1038/s41416-021-01495-7 |
Ejemplares similares
-
Contemporary oncology trials, drug approvals and the physician-patient relationship
por: Schnog, John-John B., et al.
Publicado: (2022) -
The social value of a QALY: raising the bar or barring the raise?
por: Donaldson, Cam, et al.
Publicado: (2011) -
raising the bar
por: Anand, Akshay
Publicado: (2010) -
Immune Checkpoint Inhibitors in Uro-Oncology: Urgent Call for Biomarkers
por: Pichler, Renate
Publicado: (2020) -
Raising the Bar for Levees
por: Lougheed, Tim
Publicado: (2006)